Search for Stocks /

JK Agri Genetics Ltd Q3 FY26 – ₹23.6 Cr Quarterly Sales, ₹5.27 Cr Loss, 73% Promoter Holding, and a P/E That Refuses to Blink

Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.

1. At a Glance

JK Agri Genetics Ltd is that awkward relative at the Indian equity dinner table who comes from a respected family, talks a lot about R&D, but hasn’t really cracked a consistent earnings formula in years. Market cap sits at ₹156 crore, stock price at ₹336, down ~14% in 3 months and ~18% in 6 months—basically the market saying “bhai, prove it first.”

Latest Q3 FY26 numbers didn’t help much. Revenue clocked in at ₹23.63 crore, down 9.1% YoY, while PAT was a loss of ₹5.27 crore. Operating margins were deeply negative at -32%, which is not exactly what you want from a company whose job is literally to sell seeds—nature’s most margin-friendly product.

Despite this, the stock trades at a P/E of ~110, with ROE at -13.7% and ROCE at -7.1%. Promoters hold a chunky 73.1%, debt is negligible (₹0.28 crore), and book value is ₹247, putting the stock at 1.35× P/B.

So what’s going on here? A legacy agri brand, pan-India distribution, global research tie-ups… and yet profits behave like monsoon rainfall—highly unpredictable. Curious? You should be.


2. Introduction

JK Agri Genetics Ltd belongs to the prestigious JK Group, which already gives it a surname advantage in Indian capital markets. Founded in 1989, the company operates in the agri-inputs space—primarily seeds—under the JK Seeds brand. On paper, this is a dream sector: agriculture is non-negotiable, seeds are recurring demand products, and India’s farm ecosystem keeps modernising.

But numbers don’t care about family background. Over the last 5 years, sales have de-grown at ~2% CAGR, and profitability has been on-and-off like a faulty tube light. FY24 was ugly, FY25 barely recovered, and Q3 FY26 again slipped into losses.

What makes the story interesting—and confusing—is that this isn’t a fly-by-night operator. The company runs 50+ scientists, 5 breeding research centres, 23 multi-location trial centres, and spends ₹15–16 crore annually on R&D. That’s nearly 6% of revenue, which is serious money for a ₹160-crore topline business.

So the big question:
👉 Is JK Agri Genetics a long-gestation R&D story temporarily punished by bad cycles, or is it a structurally weak business hiding behind scientific jargon?

Let’s dig.


3. Business Model – WTF Do They Even Do?

In simple terms, JK Agri Genetics develops, produces, and sells seeds. Not the “sprinkle on

Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →